Alpha-N-Dichloroacetyl-P-Aminophenylserinol

Identification

Generic Name
Alpha-N-Dichloroacetyl-P-Aminophenylserinol
DrugBank Accession Number
DB04411
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 293.146
Monoisotopic: 292.038147738
Chemical Formula
C11H14Cl2N2O3
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UChloramphenicol 3-O phosphotransferaseNot AvailableStreptomyces venezuelae (strain ATCC 10712 / CBS 650.69 / DSM 40230 / JCM 4526 / NBRC 13096 / PD 04745)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as aniline and substituted anilines. These are organic compounds containing an aminobenzene moiety.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Aniline and substituted anilines
Direct Parent
Aniline and substituted anilines
Alternative Parents
Secondary carboxylic acid amides / Secondary alcohols / Amino acids and derivatives / Primary amines / Primary alcohols / Organopnictogen compounds / Organochlorides / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
show 2 more
Substituents
Alcohol / Alkyl chloride / Alkyl halide / Amine / Amino acid or derivatives / Aniline or substituted anilines / Aromatic alcohol / Aromatic homomonocyclic compound / Carbonyl group / Carboxamide group
show 14 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
BFLNGKUCFYKCFZ-RKDXNWHRSA-N
InChI
InChI=1S/C11H14Cl2N2O3/c12-10(13)11(18)15-8(5-16)9(17)6-1-3-7(14)4-2-6/h1-4,8-10,16-17H,5,14H2,(H,15,18)/t8-,9-/m1/s1
IUPAC Name
N-[(1R,2R)-1-(4-aminophenyl)-1,3-dihydroxypropan-2-yl]-2,2-dichloroacetamide
SMILES
[H][C@](CO)(NC(=O)C(Cl)Cl)[C@]([H])(O)C1=CC=C(N)C=C1

References

General References
Not Available
PubChem Compound
445896
PubChem Substance
46504616
ChemSpider
393391
ChEBI
47325
ZINC
ZINC000002525836
PDBe Ligand
CLK
PDB Entries
1grq

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility4.97 mg/mLALOGPS
logP0.46ALOGPS
logP0.11Chemaxon
logS-1.8ALOGPS
pKa (Strongest Acidic)9.33Chemaxon
pKa (Strongest Basic)3.95Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area95.58 Å2Chemaxon
Rotatable Bond Count5Chemaxon
Refractivity70.58 m3·mol-1Chemaxon
Polarizability27.08 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.987
Blood Brain Barrier+0.9558
Caco-2 permeable-0.5332
P-glycoprotein substrateNon-substrate0.7463
P-glycoprotein inhibitor INon-inhibitor0.9763
P-glycoprotein inhibitor IINon-inhibitor0.9529
Renal organic cation transporterNon-inhibitor0.9353
CYP450 2C9 substrateNon-substrate0.829
CYP450 2D6 substrateNon-substrate0.8306
CYP450 3A4 substrateNon-substrate0.7189
CYP450 1A2 substrateInhibitor0.5088
CYP450 2C9 inhibitorNon-inhibitor0.8458
CYP450 2D6 inhibitorNon-inhibitor0.8397
CYP450 2C19 inhibitorNon-inhibitor0.7045
CYP450 3A4 inhibitorNon-inhibitor0.6449
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8735
Ames testNon AMES toxic0.5931
CarcinogenicityNon-carcinogens0.6791
BiodegradationNot ready biodegradable0.5396
Rat acute toxicity2.2579 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.996
hERG inhibition (predictor II)Non-inhibitor0.9424
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-00di-2900000000-d4a569a75b3184796eb6
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a6s-0090000000-d871e891f9baa3f2ec21
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0avi-1960000000-a1c3275e214fff76aff5
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00du-1970000000-a72a2908fde6e64ab598
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-05u5-5900000000-9924fcdf9ff597cfa645
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-00ec-6910000000-03481d6dd52300c03bb6
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00dl-5900000000-cf8989838752e7d8164f
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-161.1393137
predicted
DarkChem Lite v0.1.0
[M-H]-166.10605
predicted
DeepCCS 1.0 (2019)
[M+H]+161.7373137
predicted
DarkChem Lite v0.1.0
[M+H]+168.46407
predicted
DeepCCS 1.0 (2019)
[M+Na]+161.7973137
predicted
DarkChem Lite v0.1.0
[M+Na]+175.02333
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Streptomyces venezuelae (strain ATCC 10712 / CBS 650.69 / DSM 40230 / JCM 4526 / NBRC 13096 / PD 04745)
Pharmacological action
Unknown
General Function
Kinase activity
Specific Function
Inactivates chloramphenicol by catalyzing the transfer of the gamma-phosphate of ATP to the antibiotic's C-3' hydroxyl group.
Gene Name
Not Available
Uniprot ID
Q56148
Uniprot Name
Chloramphenicol 3-O phosphotransferase
Molecular Weight
18816.255 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52